Aenova Group

Aenova announces a major investment in its sterile manufacturing capabilities with the installation of another fill & finish line at its Latina site. The investment is approximately €100 million over three years, adding annual capacity of 30-40 million units. Construction is underway, equipment installation planned for 2026, and GMP manufacturing start in Q3 2027.